.AstraZeneca has discussed an early look at the functionality of its own in-house antibody-drug conj...
.After introducing a stage 3 launch based on beneficial midstage results, iTeos as well as GSK are f...
.The FDA should be actually much more available and collective to discharge a surge in commendations...
.It's an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 test, however the bi...
.Neurocrine Biosciences' schizophrenia program pivot has actually stopped working. The biotech was a...
.Sanofi has brought in a late entrance to the radioligand party, paying one hundred thousand europea...
.After F2G's very first try to receive a brand-new lesson of antifungal to market was wrecked due to...
.Moderna has pledged to cut R&D spending by $1.1 billion by 2027. The choice to retract the budge...
.Simply four months after Sanofi bet $80 thousand in ahead of time cash on Key Therapeutics' losmapi...